Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed March 20, 2023). ©GlobalData.

Manufacturing 130

Manufacturing Generic Drugs Contract Manufacturing Production 130

pharmaphorum

JULY 28, 2022

Logistical challenges of getting the right materials in the right place remain two years after the pandemic began, causing significant drug shortages to end-users. Many of the medicines most badly affected by these shortages are generic drugs to treat common conditions such as diabetes and heart disease.

Compliance 111

Compliance Drugs Manufacturing Generic Drugs 111

The Pharma Data

MARCH 15, 2022

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

Pharmaceutical Technology

OCTOBER 28, 2022

To demonstrate bioequivalence for a generic small molecule drug, a company must carry out a Phase I clinical trial in healthy individuals to ensure that the area under the curve and maximum plasma concentration for their drug is equivalent to that of the brand name drug.

Bioequivalency 130

Bioequivalency Production Contamination Branding 130

Pharmaceutical Technology

JUNE 6, 2023

In a 2022 annual report, the US Food and Drug Administration’s (FDA) Office of Generic Drugs stated it had approved 106 first generics— the introductory generic competitors of branded drugs.

Drugs 130

Drugs Generic Drugs FDA Approval Vaccination 130

The Pharma Data

MAY 6, 2021

. US backs giving poorer countries access to COVID-19 vaccine patents, reversing stance ( Reuters ) ( STAT ) ( NYTimes ) ( Endpoints ) ( Harvard Bill of Health ) ( KEI ) ( Patent Docs ). Drugmakers say Biden misguided over vaccine patent waiver ( Reuters ) ( FT ). billion ( Reuters ) ( WSJ ).

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

Pharmaceutical Technology

MAY 16, 2023

over Q1 2023, attributed to a surge in sales of their jointly developed drug Dupixent, which recently gained approval for the treatment of paediatric atopic dermatitis, eosinophilic oesophagitis and prurigo nodularis. Sanofi and Regeneron’s market capitalisation grew by 12.4%

Marketing 130

Marketing Sales Generic Drugs Vaccination 130

BioPharma Reporter

DECEMBER 22, 2022

Expanding generic drug competition and a decline in the demand for COVID-19 vaccines and therapies have brought down the aggregate market capitalization of the global top 20 biopharmaceutical companies by 9.1%.

Generic Drugs 52

Generic Drugs Vaccination Vaccine Marketing 52

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19.

Regulation 52

Regulation Manufacturing Drugs Medicine 52

FDA Law Blog

AUGUST 21, 2023

Brand drugs, generic drugs, and medical devices alike have all been the target of state failure-to-warn litigation; in a recent case, OTC acetaminophen is the target. Liability is precisely why the vaccine market shrunk so significantly in the 1980s, going from 26 manufacturers to 4, after lawsuits claiming $3.5

FDA Approval 40

FDA Approval Production Drugs Generic Drugs 40

The Pharma Data

NOVEMBER 26, 2020

Vaccine nationalism, just like uncoordinated national responses in a pandemic undermine progress toward getting COVID-19 under control – now more than ever we see that international cooperation is indispensable to addressing a global health crisis, there’s no other way around it, we must work together!”.

Drugs 52

Drugs Generic Drugs Medicine Vaccination 52

Drug Channels

JUNE 27, 2021

As you declare your vaccinated independence, celebrate with these Drug Channels fireworks: Amazon’s teeny step toward pharmacy disruption How patients view copay accumulators My $0.02 on generic and biosimilar trends Some hospitals seem to be gaming their 340B eligibility Plus, tips on effective hospital marketing.

Drugs 52

Drugs Pharmacy Vaccination Vaccine 52

World of DTC Marketing

APRIL 12, 2021

Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages. Most of these generics are produced outside the US and recently there have been numerous recalls of generic drugs because of the failure of quality control.

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

pharmaphorum

SEPTEMBER 9, 2022

Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Vulnerability .

Production 105

Production Pharma Companies Generic Drugs Medicine 105

World of DTC Marketing

DECEMBER 18, 2020

The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines. They will profit handsomely from these vaccines, even when they claim to be acting selflessly. were dispensed using generic drugs. New York Times.

Generic Drugs 155

Generic Drugs Drugs Pharma Companies Vaccination 155

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. billion in 2022. billion.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

STAT News

DECEMBER 14, 2022

… The Biden administration signaled it will require health plans on federal exchanges to cover more of the costs of generic drugs, a small tweak that nevertheless has industry groups divided on how best to manage drug costs , STAT reports. The Continue to STAT+ to read the full story…

Generic Drugs 98

Generic Drugs Vaccination Vaccine Regulation 98

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Adjusted Income (2).

Vaccination 40

Vaccination Vaccine Production Sales 40

FDA Law Blog

OCTOBER 24, 2024

Gibbs — A recent blog post focused on the potentially negative implications of the proposed Patent Eligibility Restoration Act (PERA) for manufacturers of generic drugs and biosimilar products. They argued that the legislation was necessary to spur innovation of new vaccines and therapies in response to emerging health threats.

Gene 64

Gene DNA Genetics Gene Sequencing 64

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. The price of that prize is incalculable.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92